Jiangsu Hengrui Medicine News and Activities

Jiangsu Hengrui Medicine is one of the...

• CSI 300;
• Forbes Global 2000 (#1201);
• TOB Iconic 10,000.

Jiangsu Hengrui Medicine is a company listed under the stock ticker 600276 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Jiangsu Hengrui Medicine

• Jo Feng, President
• Congzhao Guo, Director
• Hongbin Dai, Vice Chairman of the Board

Create your alert
to follow the executive moves at Jiangsu Hengrui Medicine.

Jiangsu Hengrui Medicine has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Jiangsu Hengrui Medicine

• 恒瑞医药
• 恒瑞医药

Social media about Jiangsu Hengrui Medicine

• Jiangsu Hengrui Medicine on Wikipedia, Google News & Yahoo Finance
• Jiangsu Hengrui Medicine on LinkedIn, X (Twitter) & YouTube